论文部分内容阅读
恶性肿瘤病人,特别是疾病晚期,机体免疾功能大多低下,而某些抗癌治疗措施对病人的免疫功能又有一定的抑制作用。目前普遍认为肿瘤病人的转归与其免疫功能状态有密切关系,所以及时了解病人在不同治疗阶段的免疫功能状态很有必要。我们选用链激酶——链道酶作为皮肤试验的抗原,用来观察迟缓性变态反应,从而判定病人机体的免疫状态。本文的内容是(一)观察肿瘤患者治疗前的免疫状态;(二)化学治疗、放射治疗对病人免疫功能的影响;(三)免疫状态与病人予后的关系。
Malignant tumor patients, especially in late disease, the body most of the low immune function, and some anti-cancer treatment measures on the patient’s immune function and have some inhibitory effect. It is generally accepted that the prognosis of patients with cancer is closely related to their immune status, so it is necessary to keep abreast of patients’ immune status at different treatment stages. We use streptokinase-linked enzyme as a skin test antigen, used to observe the delay of allergic reactions, to determine the patient’s immune status. The content of this article is to: (1) observe the immune status of tumor patients before treatment; (2) the influence of chemotherapy and radiotherapy on patient’s immune function; and (3) the relationship between immune status and patient’s post-treatment.